In summary, our study presents evidence that three of the most common TNF-α polymorphisms (rs1800629, rs361525 and rs1799724) are not associated with PCA risk, which should be verified in the future, but they may be poised to become serum biomarkers in several subgroups for the detection of PCA susceptibility. The gene discussed is TNF; the disease is posterior cortical atrophy.